Cargando…
Knockin mouse models demonstrate differential contributions of synaptotagmin-1 and -2 as receptors for botulinum neurotoxins
Botulinum neurotoxins (BoNTs) are the most potent toxins known and are also utilized to treat a wide range of disorders including muscle spasm, overactive bladder, and pain. BoNTs’ ability to target neurons determines their specificity, potency, and therapeutic efficacy. Homologous synaptic vesicle...
Autores principales: | Thaker, Hatim, Zhang, Jie, Miyashita, Shin-Ichiro, Cristofaro, Vivian, Park, SunHyun, Hashemi Gheinani, Ali, Sullivan, Maryrose P., Adam, Rosalyn M., Dong, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553082/ https://www.ncbi.nlm.nih.gov/pubmed/34662366 http://dx.doi.org/10.1371/journal.ppat.1009994 |
Ejemplares similares
-
Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells
por: Dong, Min, et al.
Publicado: (2003) -
Botulinum Neurotoxin Serotype A Recognizes Its Protein Receptor SV2 by a Different Mechanism than Botulinum Neurotoxin B Synaptotagmin
por: Weisemann, Jasmin, et al.
Publicado: (2016) -
Identification and characterization of a novel botulinum neurotoxin
por: Zhang, Sicai, et al.
Publicado: (2017) -
Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors
por: Tao, Liang, et al.
Publicado: (2017) -
On Botulinum Neurotoxin Variability
por: Montecucco, Cesare, et al.
Publicado: (2015)